Redhill Biopharma
RDHL
8 hedge funds and large institutions have $12.9M invested in Redhill Biopharma in 2014 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.
33% more funds holding
Funds holding: 6 → 8 (+2)
8% more capital invested
Capital invested by funds: $11.9M → $12.9M (+$945K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$10.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
-$114K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
O
1
OrbiMed
New York
| $8.07M | – | – | – |
|
|
BC
2
Broadfin Capital
New York
| $3.35M | -$114K | -11 | -4% |
|
|
CS
3
Candriam SCA
Strassen, Luxembourg,
Luxembourg
| $945K | +$736K | +71 | New |
|
4
Goldman Sachs
New York
| $387K | – | – | – |
|
|
MMG
5
Monetary Management Group
St Louis,
Missouri
| $52K | – | – | – |
|
6
Wells Fargo
San Francisco,
California
| $40K | – | – | – |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $15K | +$10.4K | +1 | New |
|
8
Bank of America
Charlotte,
North Carolina
| $13K | – | – | – |
|
9
UBS Group
Zurich,
Switzerland
| $5K | – | – | – |
|
10
Morgan Stanley
New York
| $2K | – | – | – |
|
RDHL Hedge Fund Activity: Q4 2014 in Review
8 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q4 2014, worth a combined $12.9M — up 7.9% from $11.9M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new RDHL positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Tower Research Capital (TRC), opening a new position worth an estimated $10.4K. The largest seller was Broadfin Capital, cutting an estimated $114K.
- 8 institutional investors held Redhill Biopharma (RDHL) as of Q4 2014, up from 6 in Q3 2014.
- Funds reported $12.9M of Redhill Biopharma stock for Q4 2014, up 7.9% quarter-over-quarter.
- 2 funds opened new Redhill Biopharma positions in Q4 2014 and 0 closed out, a net change of +2 holders.
- The largest Redhill Biopharma buyer in Q4 2014 was Tower Research Capital (TRC), an estimated $10.4K added.
- The largest Redhill Biopharma seller in Q4 2014 was Broadfin Capital, an estimated $114K sold.
Based on aggregated 13F filings for Q4 2014.